Find similar products:
The text only version may be available in large print, Braille or audio CD.
For further information call emc accessibility on
0800 198 5000.
The product code(s) for this leaflet is: PL26080/0010.
Levothyroxine SERB 200 micrograms/ml solution for injection/infusion
LEVOTHYROXINE SERB 200 micrograms/ml solution for injection/infusion
Levothyroxine sodium
1. What Levothyroxine SERB 200 micrograms/ml solution for injection/infusion is and what it is used for
2. What you need to know before you use Levothyroxine SERB 200 micrograms/ml solution for injection/infusion
3. How to use Levothyroxine SERB 200 micrograms/ml solution for injection/infusion
4. Possible side effects
5. How to store Levothyroxine SERB 200 micrograms/ml solution for injection/infusion
6. Contents of the pack and other information
Levothyroxine SERB 200 micrograms/ml solution for injection/infusion contains levothyroxine sodium which is a thyroid hormone
This medicine is used to treat severe under activity of the thyroid gland (myxoedema coma).
This medicine is also used for the treatment of hypothyroidism (insufficient activity of the thyroid gland) in replacement to oral therapy for patients who cannot swallow or have trouble taking oral medicine.
Talk to your doctor, nurse or pharmacist before using Levothyroxine SERB 200 micrograms/ml solution for injection/infusion.
Thyroid hormones are not suitable for weight reduction. Taking thyroid hormones will not reduce your weight, if your thyroid hormone level is in a normal range. Serious or even life threatening side effects may occur if you increase the dose without special advice from your doctor, especially when taken together with other medicines for weight reduction.
Thyroid imbalance may occur if you need to change your medication to another levothyroxine-containing product. Talk to your doctor if you have any questions about changing your medication. Your doctor will do blood tests and closely monitor you. You should tell your doctor if you get any side effects as this may indicate that your dose needs to be adjusted up or down.
Tell your doctor if you:
If you experience an allergic reaction (see section possible side effects). Contact your doctor or healthcare professional immediately or go to the nearest hospital emergency room right away.
If you are about to undergo laboratory testing for monitoring your thyroid hormone levels, you must inform your doctor and/or the laboratory personnel that you are taking or have recently taken biotin (also known as vitamin H, vitamin B7 or vitamin B8). Biotin may affect results of your laboratory tests. Depending on the test, the results may be falsely high or falsely low due to biotin. Your doctor may ask you to stop taking biotin before performing laboratory tests. You should also be aware that other products that you may take, such as multivitamins or supplements for hair, skin, and nails could also contain biotin. This could affect the results of laboratory tests. Please inform your doctor and/or the laboratory personnel, if you are taking such products (Please note the information in section Other medicines and LEVOTHYROXINE SERB 200 micrograms/ml solution for injection/infusion.
In all these situations, the prescription for the thyroid hormones treatment will be determined on a case-by-case basis and patients will be closely monitored
Blood pressure will be regularly monitored when levothyroxine treatment is started in very low birth weight premature babies because rapid fall in blood pressure (known as circulatory collapse) may occur.
Some medicines may affect the effectiveness of Levothyroxine SERB 200 micrograms/ml solution for injection/infusion.
Please tell your doctor or pharmacist if you are taking or have recently taken any other medicines, including medicines obtained without a prescription. In particular, tell your doctor if you are taking any of the following medicines:
If you are taking or have recently taken biotin, you must inform your doctor and/or the laboratory personnel when you are about to undergo laboratory testing for monitoring your thyroid hormone levels. Biotin may affect results of your laboratory tests (see warnings and precautions).
If you are pregnant or planning to become pregnant or are breastfeeding, ask your doctor or pharmacist for advice before taking this medicine.
The decision on whether it is in your best interests to have Levothyroxine SERB 200 micrograms/ml solution for injection/infusion during pregnancy or breast feeding will be made by your doctor.
Levothyroxine SERB 200 micrograms/ml solution for injection/infusion has no effect or a negligible effect on the ability to drive and use machines.
This medicine contains less than 1 mmol sodium (23 mg) per ampoule, that is to say essentially ‘sodium-free’.
Always use this medicine exactly as your doctor has told you. Check with your doctor or pharmacist if you are not sure.
The dose you receive vary depending on the level of your thyroid hormones, your age and how well you can tolerate the drug.
In order to give you the right dose, your doctor will check your thyroid hormones levels.
You will continue to receive a daily dose of levothyroxine for injection/infusion until you are able to tolerate an oral dose and you are clinically stable.
Adults
Myxoedema coma:
The first day: initial dose of 200 to 500 micrograms given by infusion in the vein with a maximal dose at 500 micrograms.
As a maintenance dose you will receive between 75 to 90 microgramms daily.
Hypothyroidism where oral therapy is not feasible
You will normally start with caution with 25 micrograms per day and the dosage will be increased weekly by 25 micrograms until the appropriate dosage for your condition is established. The average dose is 75 to 110 micrograms given in one injection in the muscle or in the vein.
Elderly
If you are elderly and have heart problems, your treatment will start with a lower dose and will be built up slowly.
Use in children
Myxoedema coma:
Initial dose: 10 micrograms per kilogram of bodyweight.
Maintenance dose: lower doses.
Hypothyroidism where oral therapy is not feasible
The dose will be adjusted based on your individual needs. The average dose is no more than 75% of the oral dose when given in the muscle or in the vein.
Injection (in the muscle or the vein)
For Myxoedema coma, the initial dose is preferably administered by the intravenous route.
This can cause excess thyroid hormone action and you may suffer from symptoms such as nervousness, irritability, fatigue, a fast heartbeat or insomnia. In the event of these symptoms, it is essential that you consult your doctor.
Stopping your treatment may stop the effect of the medicine. Do not stop treatment with Levothyroxine SERB 200 micrograms/ml solution for injection/infusion unless you have discussed this with your doctor.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Contact your doctor immediately for any of the following:
Other side-effects
Very common (may affect more than 1 in 10 people)
Common (may affect up to 1 in 10 people)
Rare (may affect up to 1 in 1,000 people)
Frequency not known
If you get any side effects, talk to your doctor, nurse or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via
or search for MHRA Yellow Card in the Google Play or Apple App Store.
By reporting side effects you can help provide more information on the safety of this medicine.
Store in the original package in order to protect from light.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the packaging and the ampoule after “EXP”. The expiry date refers to the last day of that month.
After opening and/or dilution: the product must be used immediately.
Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.
This medicine is supplied in the form of a clear colourless solution for injection in a 1 ml ampoule. Box of 6 ampoules.
This leaflet was last revised in January 2025.